ConductScience.org, home

Gene · 710

NIH grants1,786

NIH grants whose papers are about the gene, through NIH's grant-paper links.

461 to 480 of 1,786

Download this page as JSON
GrantTitleSERPING1 papersNewest fiscal year
I01BX004333Novel Complement-targeted treatment strategies in Renal Disease12023
K01OD031898Characterizing IL-22 driven chronic immune activation in HIV/TB co-pandemic12023
K08AG064039Astrocyte Reaction in Alzheimer's Disease12023
K08HL136898Mechanisms of Endothelial Cell Dysfunction in Critically Ill Children12023
K23AI141681Persistent DNA Hyper-Methylation of the IFN-γ Signaling Pathway During Tuberculosis12023
K23HL144916The Role of Alveolar Mononuclear Phagocytes in Acute Respiratory Distress Syndrome12023
KL2TR001424Northwestern University Clinical and Translational Science Institute (NUCATS)12023
P01AG003991Healthy Aging and Senile Dementia12023
P01AG017242DNA Repair, Mutations and Cellular Aging12023
P01CA098101Mechanisms of Esophageal Carcinogenesis12023
P01CA101937Genomics Of Acute Myeloid Leukemia.12023
P50MH103222Kynurenic Acid and Cognitive Abnormalities in Schizophrenia12023
R00HD097286Integrative analysis of human placental epi/genome in relation to fetal growth12023
R00NS111731Understanding Brain Development Through the Lens of Metabolism12023
R01AG017917Epidemiologic Study of Neural Reserve and Neurobiology of Aging12023
R01AI141434Decay Accelerating Factor and B cell Immunity12023
R01AI144120Molecular Insights into the Uropathogenesis of MDR Acinetobacter baumannii12023
R01AI145988Dissecting the impact of interferon hypersensitivity on mouse models of Down syndrome12023
R01AI158911Cohort and biomarkers for COVID-19 severity, natural history, and reinfection12023
R01AR073252IL-26 in host defense against infection by intracellular bacteria in skin12023

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/710/grants?page=24